European Thyroid Journal

Papers
(The median citation count of European Thyroid Journal is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)
ArticleCitations
Differentiated thyroid cancer in two European referral centres: impact of different diagnostic and therapeutic strategies28
IgG4 glycosylation contributes to the pathogenesis of IgG4 Hashimoto's thyroiditis via the complement pathway26
Pleural metastases from differentiated thyroid cancer: clinical features and long-term outcomes18
Long-term outcomes of LT4/LT3 combination treatment for persistent hypothyroid symptoms17
Somatic copy number deletion of chromosome 22q in papillary thyroid carcinoma13
ETA guidelines for the use of levothyroxine sodium preparations in monotherapy to optimize the treatment of hypothyroidism13
Suspected track-site seeding as an isolated deep SH–SCM papillary thyroid carcinoma lesion years after TOETVA12
TSHR in thyroid cancer: bridging biological insights to targeted strategies11
Management of benign nodular thyroid disease: a nationwide survey of endocrine specialists in Spain10
Thyroid hormone receptor α signaling shapes innate and adaptive immune responses during viral infection10
2026 ETA guideline on interference in immunoassay measurements used in assessment of thyroid function10
Back-wall cystic figures are not undoubtedly pathognomonic of benignity: malignant and infectious mimickers in thyroid lesions9
Pediatric differentiated thyroid carcinoma leading to fatal lung fibrosis9
Hypothyroid women have persistently higher oxidative stress compared to healthy controls9
The mammalian acid chitinase promotes oncogenic properties of thyroid cancer cells through the JAK2/STAT3 pathway8
Graves’ disease in ectopic thyroid tissue: a scoping review and a case study8
High-dose intravenous methylprednisolone is effective in subacute thyroiditis unresponsive to oral steroids7
50 YEARS OF NEWBORN SCREENING FOR CONGENITAL HYPOTHYROIDISM: EVOLUTION OF INSIGHTS IN ETIOLOGY, DIAGNOSIS AND MANAGEMENT: Transient or permanent congenital hypothyroidism: from milestones to current a6
Clarifying the interpretation of subdistribution hazard ratios in competing-risk analyses: comment on Riis et al. , Eur Thyroid J.6
Comparing the diagnostic accuracy of Afirma GSC to ThyroSeq V3 in cytologically indeterminate thyroid nodules6
Clinical predictors of TRAb decline after total thyroidectomy in patients with Graves’ disease6
Higher prevalence of gestational diabetes in euthyroid women with thyroid autoimmunity who were expecting a female fetus5
Acknowledgement to reviewers5
Diet plays a supportive role in managing thyroid disorders – but a critical one!5
Measuring deiodinase activity: a need for standardization?5
Adiposity is associated with a higher number of thyroid nodules and worse fine-needle aspiration outcomes5
Prevalence of endogenous normal thyroid function 3 years after hemithyroidectomy for differentiated thyroid cancer5
Newborn screening for congenital hypothyroidism: worldwide coverage 50 years after its start4
The impact of insulin resistance on thyroid function and the prevalence of thyroid follicular nodular disease in pregnant women4
Thyroid response to blocking sympathetic activity in chronic cold-exposed hunters in East Greenland: a case–control study4
The influence of age-independent somatic driver alterations on clinical outcomes in paediatric and young adult thyroid cancer4
Follow-up and transition of care for low recurrence risk thyroid cancer patients in Canada4
Long-term exposure to PM1 and thyroid diseases in China4
Triiodothyronine treatment in mice improves stroke outcome and reduces blood–brain barrier damage4
Newborn screening for central congenital hypothyroidism: past, present and future3
Potential of bone marrow mesenchymal stem cells in iodine-induced autoimmune thyroiditis therapy3
The relationship between cholesterol levels and thyroid eye disease3
Predictive factors of radioiodine ablation success: results from a MEDIRAD prospective clinical study for thyroid cancer3
Alterations in gene expression associated with invasion of RAS-mutant thyroid tumors and their potential diagnostic and therapeutic utility3
Preliminary study on ketone body metabolism in anaplastic thyroid cancer3
EUthyroid2: The next step towards the elimination of iodine deficiency and preventable iodine-related disorders in Europe and beyond3
Multifocality and bilaterality in medullary thyroid cancer: basis for a proof-of-concept safety of lobectomy3
Pathogenic MCT8V235L creates a steric clash that is alleviated by a compensating mutation of MCT8F285A3
Intramuscular and subcutaneous levothyroxine: success in treating refractory hypothyroidism3
Impact of reflexive preoperative molecular testing for indeterminate nodules on lobectomy and completion thyroidectomy rates3
Birth weight and placental weight in children born to mothers with hypothyroidism3
External validation of a microRNA thyroid classifier: a real-world prospective study3
Newborn screening and the screening laboratory: past, present and future3
Comparison of short-term outcomes following minimally invasive (endoscopic/robotic) vs open thyroidectomy for patients with thyroid cancer3
Hypercalcitoninemia in chronic kidney disease: an old issue, a new perspective?3
Real-world efficacy of lenvatinib/pembrolizumab combination in anaplastic thyroid carcinoma: case series from two Italian referral centers3
Erratum to: “Follow-up and transition of care for low recurrence risk thyroid cancer patients in Canada”3
Predictive value of baseline thyroid autoantibody titers for ICI-associated thyroid adverse events in cancer3
NSD3::NUTM1 fusion evidenced on RNA sequencing in poorly differentiated thyroid cancer: a report of two cases2
Acknowledgement to reviewers2
Preconception body mass index and maternal thyroid function: a longitudinal observational study2
Nomogram to predict the prognostic value of tumor deposits for patients with papillary thyroid carcinoma2
Evaluation of thyroid ultrasound reports’ quality in the Community of Madrid, Spain2
pT1a papillary thyroid carcinomas in pediatric patients2
Alemtuzumab-induced thyroid eye disease successfully treated with a single low-dose of rituximab2
Promise and pitfalls of AI chatbots in complex decision-making for thyroid nodules and papillary thyroid cancer2
[18F]Tetrafluoroborate, a new NIS PET/CT radiopharmaceutical: an overview focused on differentiated thyroid cancer2
Best practices in the management of thyroid dysfunction induced by immune checkpoint inhibitors2
Response to letter: ‘why so many doses, and why now?’2
Habitat imaging based on water–fat separation for interpreting extraocular muscle heterogeneity in thyroid eye disease2
Unravelling the pathogenic mechanisms in Graves’ orbitopathy2
Differences and analogies in thyroid cancer discovered incidentally or by thyroid-related screening: a multicenter study2
Plasma exchange aids thyroidectomy in refractory amiodarone-induced thyrotoxicosis, despite variable biochemical responses2
Enhancing radioactive iodine (RAI) incorporation in RAI-refractory differentiated thyroid cancer: current insights2
Salivary and lacrimal disorders in patients treated with radioiodine for differentiated thyroid cancer2
Performance of the AmpliSeq NGS panel in thyroid nodules with indeterminate cytology2
Association of maternal thyroid peroxidase antibody exposure with children’s emotional and behavioral problems2
Prevalence of treated hyper- and hypo-thyroidism and sociodemographic and geographic disparities in France in 20202
Pathologic and radiologic response to neoadjuvant therapy in advanced differentiated thyroid cancer2
Changing the paradigm: lobectomy for sporadic medullary thyroid cancer1
Standardization of TSH and FT4 to gestational age in early pregnancy and associations with clinical outcomes1
Acknowledgement to reviewers1
Minimal or absent tumor desmoplasia predicts lower recurrence risk in papillary thyroid carcinoma1
In Memoriam: Jacques-Emile Dumont (1931–2023)1
Assessing the sodium-iodide symporter (NIS) in pediatric differentiated thyroid carcinoma1
Risk-adapted therapy in pediatric thyroid cancer: initial experience from a national reference program by the MET group1
50 YEARS OF NEWBORN SCREENING FOR CONGENITAL HYPOTHYROIDISM: EVOLUTION OF INSIGHTS IN ETIOLOGY, DIAGNOSIS AND MANAGEMENT: Management during pregnancy and long-term outcomes of adult patients with cong1
Investigating factors influencing quality of life in thyroid eye disease: insight from machine learning approaches1
Anticancer drug therapy for anaplastic thyroid cancer1
Investigating factors associated with thyroid hormone measurements during pregnancy1
Natural course of subclinical hyperthyroidism in primary care in the Netherlands1
Artificial intelligence-assisted risk stratification of thyroid nodules with atypia of undetermined significance1
Extreme resistance to thyroid hormone caused by a novel mosaic thyroid hormone receptor beta mutation1
Not a lymph node: ultrasonographic identification of a double pyramidal lobe of the thyroid gland1
MAPK13 promotes the progression of papillary thyroid cancer1
Brain fatigue in Graves’ disease: symptoms and presentation of a possible mechanism at the cellular level1
lncRNAs: a new generation of targets and biomarkers in thyroid cancer1
Predictors of retreatment after radiofrequency ablation of benign thyroid nodules: role of pre-treatment growth rate and viable volume1
The impact of autoimmune thyroid disease on cognitive and psychiatric disorders: focus on clinical, pre-clinical and molecular studies1
Reply to the letter by Dr Karlsson ‘Rationale behind the European Thyroid Association 2024 Guideline to treat the Allan–Herndon–Dudley syndrome with tiratricol?’1
Acknowledgement to reviewers1
Prevalence and severity of fatigue in treated hypothyroidism: results of a UK survey1
Development of animal models to study aggressive thyroid cancers1
0.029921054840088